A detailed history of Blair William & CO transactions in Danaher Corp stock. As of the latest transaction made, Blair William & CO holds 1,764,997 shares of DHR stock, worth $411 Million. This represents 1.47% of its overall portfolio holdings.

Number of Shares
1,764,997
Previous 1,777,030 0.68%
Holding current value
$411 Million
Previous $444 Million 10.51%
% of portfolio
1.47%
Previous 1.39%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$239.25 - $280.76 $2.88 Million - $3.38 Million
-12,033 Reduced 0.68%
1,764,997 $491 Million
Q2 2024

Aug 12, 2024

BUY
$235.51 - $267.98 $3.71 Million - $4.22 Million
15,766 Added 0.9%
1,777,030 $444 Million
Q1 2024

May 09, 2024

BUY
$224.58 - $256.19 $8.2 Million - $9.35 Million
36,503 Added 2.12%
1,761,264 $440 Million
Q4 2023

Feb 12, 2024

BUY
$185.1 - $233.13 $7.27 Million - $9.15 Million
39,257 Added 2.33%
1,724,761 $399 Million
Q3 2023

Nov 09, 2023

BUY
$233.08 - $265.59 $5.45 Million - $6.21 Million
23,382 Added 1.41%
1,685,504 $418 Million
Q2 2023

Aug 11, 2023

BUY
$224.99 - $256.14 $4.45 Million - $5.06 Million
19,761 Added 1.2%
1,662,122 $399 Million
Q1 2023

May 12, 2023

BUY
$239.75 - $277.0 $1.48 Million - $1.71 Million
6,191 Added 0.38%
1,642,361 $414 Million
Q4 2022

Feb 10, 2023

BUY
$241.42 - $282.29 $7.81 Million - $9.13 Million
32,344 Added 2.02%
1,636,170 $434 Million
Q3 2022

Nov 09, 2022

BUY
$247.06 - $1507.4 $20.3 Million - $124 Million
82,249 Added 5.41%
1,603,826 $414 Million
Q2 2022

Aug 10, 2022

SELL
$237.11 - $299.66 $6.79 Million - $8.58 Million
-28,630 Reduced 1.85%
1,521,577 $386 Million
Q1 2022

May 13, 2022

SELL
$257.27 - $315.76 $3.52 Million - $4.32 Million
-13,697 Reduced 0.88%
1,550,207 $455 Million
Q4 2021

Feb 14, 2022

SELL
$292.08 - $329.01 $2.49 Million - $2.8 Million
-8,524 Reduced 0.54%
1,563,904 $515 Million
Q3 2021

Nov 12, 2021

SELL
$272.21 - $332.43 $10.4 Million - $12.7 Million
-38,276 Reduced 2.38%
1,572,428 $479 Million
Q2 2021

Aug 12, 2021

BUY
$225.08 - $271.69 $2.56 Million - $3.09 Million
11,390 Added 0.71%
1,610,704 $432 Million
Q1 2021

May 13, 2021

SELL
$212.38 - $245.9 $903,676 - $1.05 Million
-4,255 Reduced 0.27%
1,599,314 $360 Million
Q4 2020

Feb 09, 2021

SELL
$212.5 - $245.46 $701,887 - $810,754
-3,303 Reduced 0.21%
1,603,569 $356 Million
Q3 2020

Nov 06, 2020

SELL
$177.16 - $215.33 $8.91 Million - $10.8 Million
-50,310 Reduced 3.04%
1,606,872 $346 Million
Q2 2020

Aug 12, 2020

BUY
$128.7 - $176.83 $392,921 - $539,861
3,053 Added 0.18%
1,657,182 $293 Million
Q1 2020

May 11, 2020

SELL
$121.39 - $169.05 $16.8 Million - $23.5 Million
-138,785 Reduced 7.74%
1,654,129 $229 Million
Q4 2019

Feb 13, 2020

BUY
$133.47 - $153.48 $781,600 - $898,778
5,856 Added 0.33%
1,792,914 $275 Million
Q3 2019

Nov 12, 2019

SELL
$135.4 - $146.47 $3.03 Million - $3.28 Million
-22,372 Reduced 1.24%
1,787,058 $258 Million
Q2 2019

Aug 13, 2019

BUY
$124.88 - $143.73 $7.68 Million - $8.84 Million
61,480 Added 3.52%
1,809,430 $259 Million
Q1 2019

May 14, 2019

BUY
$97.62 - $132.29 $8.96 Million - $12.1 Million
91,804 Added 5.54%
1,747,950 $231 Million
Q4 2018

Feb 14, 2019

BUY
$94.85 - $109.54 $1.89 Million - $2.18 Million
19,908 Added 1.22%
1,656,146 $171 Million
Q3 2018

Nov 13, 2018

BUY
$98.13 - $108.9 $1.01 Million - $1.12 Million
10,276 Added 0.63%
1,636,238 $178 Million
Q2 2018

Aug 13, 2018

BUY
$96.1 - $103.24 $1.65 Million - $1.77 Million
17,166 Added 1.07%
1,625,962 $160 Million
Q1 2018

May 15, 2018

SELL
$92.16 - $103.8 $10.2 Million - $11.5 Million
-110,589 Reduced 6.43%
1,608,796 $158 Million
Q4 2017

Feb 14, 2018

SELL
$85.26 - $94.62 $535,518 - $594,308
-6,281 Reduced 0.36%
1,719,385 $160 Million
Q3 2017

Nov 13, 2017

BUY
$79.29 - $88.45 $137 Million - $153 Million
1,725,666
1,725,666 $148 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $170B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Blair William & CO Portfolio

Follow Blair William & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.